Back to the Lab

Strategy, Perspectives

Why Digital Still Feels Like a Guessing Game in Medical Device Marketing

In Episode 2 of The Pour, Moxie Labs founder James Koran sits down with healthcare marketing leader Alex Hetzel to explore why digital marketing continues to be undervalued in the medical device industry. From launch planning and commercialization to building internal buy-in and proving ROI, they discuss what it takes to make digital a strategic growth driver rather than an afterthought.

July 7, 2026

The Pour logo and screenshots of two men drinking coffee

The Pour, Episode 2 | Moxie Labs

If you've worked in regulated industries like medical device marketing, you've probably watched this play out. The launch budget gets finalized. Sales enablement is in. Events make the cut. And then someone looks at the digital line item and the conversation stalls.

In Episode 2 of The Pour, James Koran sits down with Alex Hetzel, a healthcare marketing leader with experience across Abbott, Terumo, and Globus Medical. Alex has been in those rooms. He knows how the conversation goes and what it costs when digital gets cut.

They talk about why digital is still being treated as a support function in an industry where buyers are doing most of their research before a rep ever calls. They get into what it takes to build internal confidence in a digital program before you have years of proof to point to. James shares how the Moxie team approaches that challenge with clients who are trying to move faster than their organization is ready for.

If you're responsible for launch performance, commercial strategy, or just trying to make the case for digital investment, this one is worth your time.

Watch Episode 2 below.

The Pour is a Moxie Labs video series featuring candid conversations with leaders, marketers, and innovators. One guest, one question, finished before the coffee got cold.